Clonidine is a medication used to treat high blood pressure, Attention Deficit Hyperactivity Disorder (ADHD), and anxiety disorders. It is a central alpha-2 agonist that works by decreasing the activity of the sympathetic nervous system, which regulates blood pressure and heart rate. It has been used for decades to treat these conditions, but like all medications, there is a risk of overdose. In this article, we will discuss the dangers of clonidine overdose, how to recognize the signs and symptoms, and how to avoid it.
Clonidine is a prescription medication used to treat high blood pressure, Attention Deficit Hyperactivity Disorder (ADHD), and anxiety disorders. It is a central alpha-2 agonist that works by decreasing the activity of the sympathetic nervous system, which regulates blood pressure and heart rate. It is usually taken as a pill, but can also be taken as a patch or liquid.
Clonidine overdose can be dangerous and even fatal. Signs and symptoms of a clonidine overdose may include: confusion, dizziness, drowsiness, dry mouth, nausea, vomiting, constipation, weakness, low blood pressure, slow heart rate, and respiratory depression. In severe cases, an overdose can lead to coma and death.
It is important to be aware of the signs and symptoms of a clonidine overdose. If you or someone you know is taking clonidine and is exhibiting any of the following symptoms, seek medical attention immediately: confusion, dizziness, drowsiness, dry mouth, nausea, vomiting, constipation, weakness, low blood pressure, slow heart rate, and respiratory depression.
The best way to avoid a clonidine overdose is to take the medication as prescribed by your doctor. Do not take more than the recommended dose and do not take it more often than prescribed.
Clonidine is a medication used to treat high blood pressure, Attention Deficit Hyperactivity Disorder (ADHD), and anxiety disorders. While it is effective in treating these conditions, there is a risk of overdose. The dangers of clonidine overdose include confusion, dizziness, drowsiness, dry mouth, nausea, vomiting, constipation, weakness, low blood pressure, slow heart rate, and respiratory depression.
1.
Belgian Algorithm Reshapes Endometrial Cancer Care
2.
ASCO: Durvalumab plus FLOT beneficial for resectable gastric, GE junction cancer
3.
Nuclear missile workers are contracting cancer: They blame the bases
4.
On all CAR-T products, the FDA is calling for a new boxed warning.
5.
ASCO Future Focus: Metastatic Breast Cancer: Future Focus from the American Society of Clinical Oncology
1.
Understanding SVR Normal Range: A Guide to Achieving Optimal Health
2.
Consensus Recommendations for Healthy Hematologic Aging
3.
The Role of Alanine Aminotransferase in Liver Health and Disease
4.
Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers
5.
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Efficient Management of First line ALK-rearranged NSCLC - Part II
2.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
3.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
4.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
5.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation